Page 5 - Technologies Munich News Today

An international collaboration between Bruce Power, Isogen (a Kinectrics and Framatome company) and ITM Isotope Technologies Munich (ITM), announced the commencement of commercial production of lutetium-177.

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

ITM to supply its medical radioisotope, no-carrier-added Lutetium-177, for the clinical development of Y-mAbs' Targeted Radionuclide Therapy candidate GD2-SADA: 177Lu-DOTA Complex for GD2-positive solid

Investegate announcements from ITM Isotope Technologies Munic, ITM Signs Clinical Supply Agreement with Y-mAbs for n.c.a. Lutetium-177

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Bruce Power and Kinectrics-Framatome joint venture Isogen are examining the feasibility of producing the medical radioisotope yttrium-90 using the innovative Isotope Production System installed in unit 7 at Bruce Power's nuclear power plant in Ontario.

A first-of-its-kind isotope production system at Bruce Power has successfully produced a medical isotope used in cancer treatments.

A first-of-its-kind isotope production system at Bruce Power has successfully produced a medical isotope used in cancer treatments.

Lutetium-177 has been produced using a new isotope production system that was installed in unit 7 of the Bruce plant in Ontario, Canada, during a recent planned maintenance outage. It marks the first time the short-lived medical isotope has been produced in a commercial nuclear power reactor.

Bruce Power says a new system at its Tiverton site has successfully produced a medical isotope. The nuclear energy company says it achieved the milest...